Bionomics Ltd BNOX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:15 PM EDT
0.9399quote price arrow up+0.0291 (+3.195%)
Volume
7,496
52 week range
0.84 - 6.41
Loading...
  • Open0.93
  • Day High0.94
  • Day Low0.9171
  • Prev Close0.9108
  • 52 Week High6.41
  • 52 Week High Date09/28/23
  • 52 Week Low0.84
  • 52 Week Low Date05/01/24

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-36.49

KEY STATS

  • Open0.93
  • Day High0.94
  • Day Low0.9171
  • Prev Close0.9108
  • 52 Week High6.41
  • 52 Week High Date09/28/23
  • 52 Week Low0.84
  • 52 Week Low Date05/01/24
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-36.49

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Bionomics Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Bionomics Ltd is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on development of novel drug candidates focused on the treatment of serious central nervous system disorders. It is developing novel allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need. It is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric...
Alan Fisher
Non-Executive Independent Chairman of the Board
Spyridon Papapetropoulos
President, Chief Executive Officer
Timothy Cunningham CPA
Chief Financial Officer
Liz Doolin
Vice President - Clinical Development
Address
200 Greenhill Road
Thebarton, SA
5063
Australia